Christoph U. Correll, MD

Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York; Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York; Department of Child and Adolescent Psychiatry, Charité–Universitätsmedizin Berlin, Berlin, Germany; German Center for Mental Health (DZPG), Partner Site Berlin, Berlin, Germany

JCP
Economic Impact of Cognitive Impairment and Negative Symptoms in Schizophrenia
PCC
Alternative Treatment for Agitation in Schizophrenia and Bipolar Disorder
JCP
The Clinician’s Tardive Inventory
JCP
Relative Risk of Breast Cancer Associated With Prolactin-Increasing Antipsychotic Use
JCP
Outcome Predictors in Youth With Mental Disorders
JCP
Olanzapine/Samidorphan Mitigates Weight Gain in Early Illness
PCC
State of the Art of Diagnostics and Genetics in Huntington’s Chorea
JCP
Patient Functioning and Life Engagement: Treatment Goals in MDD
JCP
Patient Functioning, Life Engagement, and Treatment Goals in Major Depressive Disorder
JCP
Reasons for Switching Antipsychotic Treatments
JCP
Patient Functioning and Life Engagement: Treatment Goals in Schizophrenia
JCP
Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia